Optic neuritis following COVID-19 vaccination: Do autoimmune diseases play a role?

We report two cases of optic neuritis following Pfizer-BioNTech COVID-19 vaccination in patients with autoimmune diseases. Post-vaccine optic neuritis, although rare, is reported in the literature and an autoimmune mechanism seems to be involved, especially in genetically predisposed subjects. Repor...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:European journal of ophthalmology Ročník 33; číslo 4; s. NP46
Hlavní autori: Pirani, Vittorio, Pelliccioni, Paolo, Carpenè, Maria Jolanda, Nicolai, Michele, Barbotti, Federica, Franceschi, Alessandro, Mariotti, Cesare
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.07.2023
Predmet:
ISSN:1724-6016, 1724-6016
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract We report two cases of optic neuritis following Pfizer-BioNTech COVID-19 vaccination in patients with autoimmune diseases. Post-vaccine optic neuritis, although rare, is reported in the literature and an autoimmune mechanism seems to be involved, especially in genetically predisposed subjects. Report of two cases of optic neuritis following COVID-19 vaccination in patients with autoimmune diseases. He novelty of this article is the fact that the two patients had a medical history of autoimmune diseases (Hashimoto thyroiditis and ankylosing spondylitis), a point of interest for research because it is not yet clear whether this could constitute a risk factor for adverse events after vaccination. The reactogenicity of COVID-19 mRNA vaccine in individuals suffering from immune-mediated diseases is yet to be elucidated and it is being increasingly investigated. Our paper supports the hypothesis that patients who are already affected or predisposed to autoimmune or autoinflammatory disorders should be carefully evaluated for the benefits and risks of COVID-19 mRNA vaccination.
AbstractList We report two cases of optic neuritis following Pfizer-BioNTech COVID-19 vaccination in patients with autoimmune diseases. Post-vaccine optic neuritis, although rare, is reported in the literature and an autoimmune mechanism seems to be involved, especially in genetically predisposed subjects.PURPOSE AND CONTEXTWe report two cases of optic neuritis following Pfizer-BioNTech COVID-19 vaccination in patients with autoimmune diseases. Post-vaccine optic neuritis, although rare, is reported in the literature and an autoimmune mechanism seems to be involved, especially in genetically predisposed subjects.Report of two cases of optic neuritis following COVID-19 vaccination in patients with autoimmune diseases.METHODReport of two cases of optic neuritis following COVID-19 vaccination in patients with autoimmune diseases.He novelty of this article is the fact that the two patients had a medical history of autoimmune diseases (Hashimoto thyroiditis and ankylosing spondylitis), a point of interest for research because it is not yet clear whether this could constitute a risk factor for adverse events after vaccination.KEY RESULTSHe novelty of this article is the fact that the two patients had a medical history of autoimmune diseases (Hashimoto thyroiditis and ankylosing spondylitis), a point of interest for research because it is not yet clear whether this could constitute a risk factor for adverse events after vaccination.The reactogenicity of COVID-19 mRNA vaccine in individuals suffering from immune-mediated diseases is yet to be elucidated and it is being increasingly investigated. Our paper supports the hypothesis that patients who are already affected or predisposed to autoimmune or autoinflammatory disorders should be carefully evaluated for the benefits and risks of COVID-19 mRNA vaccination.CONCLUSIONSThe reactogenicity of COVID-19 mRNA vaccine in individuals suffering from immune-mediated diseases is yet to be elucidated and it is being increasingly investigated. Our paper supports the hypothesis that patients who are already affected or predisposed to autoimmune or autoinflammatory disorders should be carefully evaluated for the benefits and risks of COVID-19 mRNA vaccination.
We report two cases of optic neuritis following Pfizer-BioNTech COVID-19 vaccination in patients with autoimmune diseases. Post-vaccine optic neuritis, although rare, is reported in the literature and an autoimmune mechanism seems to be involved, especially in genetically predisposed subjects. Report of two cases of optic neuritis following COVID-19 vaccination in patients with autoimmune diseases. He novelty of this article is the fact that the two patients had a medical history of autoimmune diseases (Hashimoto thyroiditis and ankylosing spondylitis), a point of interest for research because it is not yet clear whether this could constitute a risk factor for adverse events after vaccination. The reactogenicity of COVID-19 mRNA vaccine in individuals suffering from immune-mediated diseases is yet to be elucidated and it is being increasingly investigated. Our paper supports the hypothesis that patients who are already affected or predisposed to autoimmune or autoinflammatory disorders should be carefully evaluated for the benefits and risks of COVID-19 mRNA vaccination.
Author Barbotti, Federica
Mariotti, Cesare
Franceschi, Alessandro
Carpenè, Maria Jolanda
Pirani, Vittorio
Nicolai, Michele
Pelliccioni, Paolo
Author_xml – sequence: 1
  givenname: Vittorio
  surname: Pirani
  fullname: Pirani, Vittorio
  organization: Eye Clinic, Polytechnic University of Marche, Ancona, Italy
– sequence: 2
  givenname: Paolo
  orcidid: 0000-0002-6024-0183
  surname: Pelliccioni
  fullname: Pelliccioni, Paolo
  organization: Eye Clinic, Polytechnic University of Marche, Ancona, Italy
– sequence: 3
  givenname: Maria Jolanda
  surname: Carpenè
  fullname: Carpenè, Maria Jolanda
  organization: Eye Clinic, Polytechnic University of Marche, Ancona, Italy
– sequence: 4
  givenname: Michele
  orcidid: 0000-0001-8302-6107
  surname: Nicolai
  fullname: Nicolai, Michele
  organization: Eye Clinic, Polytechnic University of Marche, Ancona, Italy
– sequence: 5
  givenname: Federica
  surname: Barbotti
  fullname: Barbotti, Federica
  organization: Private practice, Area Vasta 2, Fabriano, Italy
– sequence: 6
  givenname: Alessandro
  orcidid: 0000-0001-8867-4488
  surname: Franceschi
  fullname: Franceschi, Alessandro
  organization: Eye Clinic, Polytechnic University of Marche, Ancona, Italy
– sequence: 7
  givenname: Cesare
  surname: Mariotti
  fullname: Mariotti, Cesare
  organization: Eye Clinic, Polytechnic University of Marche, Ancona, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35957600$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1Kw0AYRQepaK0-gBuZpZvofJP5ixuR1p9CoSDqNkwmX2UgmYmZxNK3t2AFV_cuDgfuPSOTEAMScgnsBkDrWwDOlObAOQAYnasjMgXNRaYYqMm_fkJOc1lIrRibktd1N3hHA469H3yim9g0cevDJ52vP5aLDAr6bZ3zwQ4-hju6iNSOQ_RtOwaktU9oEybaNXZHLe1jg_fn5Hhjm4QXh5yR96fHt_lLtlo_L-cPq8yJ3AyZ5LJiUhXIRVUIJja6ZqpWmAupa2tcxVAaIZApYxkz4CB3heSFNvuZwCs-I9e_3q6PXyOmoWx9ctg0NmAcU8k142DyXLA9enVAx6rFuux639p-V_79wH8APKdcDA
CitedBy_id crossref_primary_10_1007_s10792_024_02948_7
crossref_primary_10_3389_fcimb_2024_1345683
crossref_primary_10_1136_bmjophth_2023_001336
crossref_primary_10_1097_WNO_0000000000002161
crossref_primary_10_3390_vaccines12030334
crossref_primary_10_3390_vaccines10101758
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1177/11206721221118736
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 1724-6016
ExternalDocumentID 35957600
Genre Journal Article
Case Reports
GroupedDBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c438t-525b0569e24b9404f7d06d6e3457da8cb0e5844e068a0081c13c95297806712b2
IEDL.DBID 7X8
ISICitedReferencesCount 8
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000839889200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1724-6016
IngestDate Thu Jul 10 17:37:48 EDT 2025
Thu Apr 03 07:06:56 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords optic neuropathy
Neuro ophthalmology
immunology
neuro imaging
optic neuritis
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c438t-525b0569e24b9404f7d06d6e3457da8cb0e5844e068a0081c13c95297806712b2
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ORCID 0000-0002-6024-0183
0000-0001-8302-6107
0000-0001-8867-4488
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC9379598
PMID 35957600
PQID 2702183340
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2702183340
pubmed_primary_35957600
PublicationCentury 2000
PublicationDate 2023-07-01
PublicationDateYYYYMMDD 2023-07-01
PublicationDate_xml – month: 07
  year: 2023
  text: 2023-07-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle European journal of ophthalmology
PublicationTitleAlternate Eur J Ophthalmol
PublicationYear 2023
Score 2.3715813
Snippet We report two cases of optic neuritis following Pfizer-BioNTech COVID-19 vaccination in patients with autoimmune diseases. Post-vaccine optic neuritis,...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage NP46
SubjectTerms Autoimmune Diseases - complications
COVID-19 - prevention & control
COVID-19 Vaccines - adverse effects
Humans
Male
Optic Neuritis - etiology
Vaccination - adverse effects
Title Optic neuritis following COVID-19 vaccination: Do autoimmune diseases play a role?
URI https://www.ncbi.nlm.nih.gov/pubmed/35957600
https://www.proquest.com/docview/2702183340
Volume 33
WOSCitedRecordID wos000839889200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qevDiA1_riwheg22aNqmXRXZd9ODuIip7K0mawIK0q_sQ_70zbRdPguClt0KZTGe-mS_zDSFXUCNAVg0cc85yJkwcMG1kynwMBXYUGmO9rpZNyMFAjcfpqGm4zZprlauYWAXqvLTYI7_GuSlwv0gEnek7w61RyK42KzTWSSsCKINeLcfV9JvkgqHSSENkosYSIAvkHUMONU-oZJT8Diqr5NLf-e9n7ZLtBlbS29oP9siaK_bJ0xDigaUoWYnKRdTDmZefkKtod_j60GNhSpfa2kndELyhvZLqxbyc4MiIow11M6PTN_1FNcV7iJ0D8tK_e-7es2aHArMiUnOoM2MDGCd1XJhUBMLLPEjyxEUilrlW1gQOIIhwQaI0wgMbRjaNOeoSJTLkhh-SjaIs3DGhFhCukR4CokqE9c74JNYqiDxXOk2UaZPLlYky8FEkHnThysUs-zFSmxzVds6mtZhGhoPBSA6e_OHtU7KF297r27JnpOXhD3XnZNMuwYgfF9Xhw3MwevwGCbO4wA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optic+neuritis+following+COVID-19+vaccination%3A+Do+autoimmune+diseases+play+a+role%3F&rft.jtitle=European+journal+of+ophthalmology&rft.au=Pirani%2C+Vittorio&rft.au=Pelliccioni%2C+Paolo&rft.au=Carpen%C3%A8%2C+Maria+Jolanda&rft.au=Nicolai%2C+Michele&rft.date=2023-07-01&rft.issn=1724-6016&rft.eissn=1724-6016&rft.volume=33&rft.issue=4&rft.spage=NP46&rft_id=info:doi/10.1177%2F11206721221118736&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1724-6016&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1724-6016&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1724-6016&client=summon